Oral antifungal agents for onychomycosis

被引：28

作者：

Gupta, AK

Scher, RK

机构：

[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada

[2] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA

来源：

LANCET | 1998年 / 351卷 / 9102期

关键词：

D O I：

10.1016/S0140-6736(05)78552-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：541 / 542

页数：2

共 16 条

[11]

Havu V, 1997, BRIT J DERMATOL, V136, P230, DOI 10.1111/j.1365-2133.1997.tb14902.x

[12] KINETICS AND SPECTRUM OF ACTIVITY OF ORAL ANTIFUNGALS - THE THERAPEUTIC IMPLICATIONS [J].

MEINHOF, W .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (01) :S37-S41

[13] Nail incorporation kinetics of terbinafine in onychomycosis patients [J].

Schatz, F ;

Brautigam, M ;

Dobrowolski, E ;

Effendy, I ;

Haberl, H ;

Mensing, H ;

Weidinger, G ;

Stutz, A .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (05) :377-383

[14] ONYCHOMYCOSIS IS MORE THAN A COSMETIC PROBLEM [J].

SCHER, RK .

BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 :15-15

[15]

SCHER RK, 1997, 37 INT C ANT AG CHEM

[16] Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy [J].

Tausch, I ;

Brautigam, M ;

Weidinger, G ;

Jones, TC ;

Tausch, I ;

Bohm, K ;

Schmidt, U ;

Westphal, HJ ;

Wurdel, C ;

Schopf, R ;

Rosinus, A ;

Schafer, B ;

Jung, FG ;

Schell, E ;

Schweiss, D ;

Happle, R ;

Schopf, E ;

Falkner, G ;

Altmeyer, P ;

Mensing, H ;

Borelli, S ;

Engst, R ;

Paetzold, FW ;

Berns, W ;

Marghescu, S ;

Fritz, F ;

Scherwitz, C ;

Goos, M ;

Brinkmann, C ;

Khamssi, M ;

Haneke, E ;

Lacour, T ;

Brautigam, M ;

Weidinger, G ;

Petry, G ;

Tanke, R ;

Heinrich, H ;

Geisler, U .

BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (05) :737-742

← 1 2 →